CLINICAL_TRIALS
trial_result
· 2019-06-06
Clinical Trial Update: Dysport in the Treatment of Glabellar Lines in Chinese Subjects [Phase 3]
Summary
Phase 3 trial update for Dysport in treating glabellar lines in Chinese subjects has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED | Results posted: 2019-06-06